http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2180117-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1f9f46f085eca7f7b8f2cc3e3cc53c6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 1994-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65090ffde1bd3ccb7f5ba17aa5441817
publicationDate 1996-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2180117-A1
titleOfInvention Combination of chemical compounds used as a medicament intended to suppress the dependence of individuals to opioids
abstract Drug combination as a medicament, intented to suppress the dependence of individuals to opiates, the combination comprising a laxative or an enema for irrigation, repeated doses of alpha-adrenergic agents, antiemetics, gastric protectors, optionally, inhibitors of the proton pump, an anxiolitic drug, doses of anesthesic sleep inducing agents and determined doses of an opiate antagonist drug, such as naxalone or naltrexo-ne.
priorityDate 1994-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3826
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506430
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412536980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121

Total number of triples: 39.